Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

Shares of DexCom Inc. DXCM rallied 3.79% to $73.38 Wednesday, on what proved to be an all-around positive trading session for ...

Both stocks should deliver excellent returns to investors patient enough to hold through volatility. Equity markets started ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Dexcom (Nadsaq:DXCM) announced today that it launched a new multi-region report evaluating type 2 diabetes treatments.

Dexcom (Nadsaq:DXCM) today announced new insulin delivery integrations and updates on enhanced continuous glucose monitors ...

DexCom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, today announced the launch of its first multi-region report, the "Dexcom State of Type 2 Report: Access and Attitudes Across Europe ...

Dexcom, the local maker of continuous glucose monitors, received a warning letter from the Food and Drug Administration last ...

DexCom Inc. closed 51.77% below its 52-week high of $142.00, which the company achieved on March 26th.

The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...

DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz.

Shares of DexCom Inc. slipped 9.15% to $70.72 Monday, on what proved to be an all-around poor trading session for the stock ...